75%Confidence
0Views
FDASource
2026-04-21Date
Summary
A Fresenius Kabi sterility recall distributed by BD involves a 100mL sodium chloride bag, potentially affecting BD's supply chain and reputation. This collaboration risk may lead BD to reconsider its partnership or sourcing strategies.
Actionable: Evaluate BD's exposure to Fresenius Kabi's manufacturing issues and its contingency plans for securing alternative suppliers.
AI Confidence: 75%
Data Points
firmFresenius Kabi USA, LLC
classificationClass II
statusOngoing
distributionUS Nationwide , Alaska, and Puerto Rico.
product0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now